{"id":470996,"date":"2021-04-05T13:38:30","date_gmt":"2021-04-05T17:38:30","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470996"},"modified":"2021-04-05T13:38:30","modified_gmt":"2021-04-05T17:38:30","slug":"hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/","title":{"rendered":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys"},"content":{"rendered":"
\n

SAN FRANCISCO, April 05, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) <\/strong>investors with significant losses to submit your losses now<\/a>.<\/p>\n\n\n\n\n\n\n
\n Class Period:<\/strong>\n <\/td>\nAug. 7, 2019 \u2013 Feb. 26, 2021<\/td>\n<\/tr>\n
\n Lead Plaintiff Deadline:<\/strong>\n <\/td>\nMay 3, 2021<\/td>\n<\/tr>\n
\n Visit:<\/strong>\n <\/td>\nwww.hbsslaw.com\/investor-fraud\/ATNX<\/td>\n<\/tr>\n
\n Contact An Attorney Now:<\/strong>\n <\/td>\n\n ATNX@hbsslaw.com<\/a>\n <\/td>\n<\/tr>\n
\u00a0<\/td>\n\n 844-916-0895<\/strong>\n <\/td>\n<\/tr>\n<\/table>\n

\n Athenex, Inc. (NASDAQ: ATNX) Securities Class Action:<\/strong>\n <\/p>\n

The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer.<\/p>\n

Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the primary endpoint of objective response rate (ORR), which might have introduced unmeasured bias and influence on the blinded independent central review (BICR); (iii) the Company\u2019s Phase 3 study did not include a representative population; and (v) as a result, it was foreseeable that the FDA would not approve the Company\u2019s NDA in its current form.<\/p>\n

On Mar. 1, 2021, the market learned the truth when Athenex announced it received the FDA\u2019s complete response letter (\u201cCRL\u201d) to the NDA for oral paclitaxel plus encequidar. In the CRL, the FDA cited safety risks to patients in terms of an increase in neutropenia-related sequalae. The CRL also cited uncertainty over the results of the primary endpoint of the ORR at week 19, which might have introduced unmeasured bias and influence on the BICR. The FDA further recommended that \u201cAthenex conduct a new adequate and well-conducted clinical trial in a patient population with metastatic breast cancer representative of the population in the U.S.\u201d<\/p>\n

On this news, shares of Athenex stock fell approximately 55% in one day.<\/p>\n

\u201cWe\u2019re focused on investors\u2019 losses and proving Athenex intentionally misled investors about its leading drug candidate,\u201d said Reed Kathrein, the Hagens Berman partner leading the investigation.<\/p>\n

If you are an Athenex investor and have significant losses, or have knowledge that may assist the firm\u2019s investigation, click here to discuss your legal rights with Hagens Berman<\/a>.<\/p>\n

\n Whistleblowers: <\/strong>Persons with non-public information regarding Athenex should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895<\/strong> or email ATNX@hbsslaw.com<\/a>.<\/p>\n

\n
\n About Hagens Berman<\/u>
\n <\/a>
\n
Hagens Berman is a national law firm with nine offices in eight cities around the country and eighty attorneys. The firm represents investors, whistleblowers, workers and consumers in complex litigation.\u00a0\u00a0 More about the firm and its successes is located at hbsslaw.com<\/a>. For the latest news visit our newsroom<\/u><\/a> or follow us on Twitter at @classactionlaw<\/u><\/a>.<\/p>\n

\n Contact: <\/u>
\n
Reed Kathrein, 844-916-0895<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SAN FRANCISCO, April 05, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 \u2013 Feb. 26, 2021 Lead Plaintiff Deadline: May 3, 2021 Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the … <\/p>\n

Continue reading “HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470996","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nHAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO, April 05, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 \u2013 Feb. 26, 2021 Lead Plaintiff Deadline: May 3, 2021 Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the … Continue reading "HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-05T17:38:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys\",\"datePublished\":\"2021-04-05T17:38:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/\"},\"wordCount\":495,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/\",\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=\",\"datePublished\":\"2021-04-05T17:38:30+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/","og_locale":"en_US","og_type":"article","og_title":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk","og_description":"SAN FRANCISCO, April 05, 2021 (GLOBE NEWSWIRE) — Hagens Berman urges Athenex, Inc. (NASDAQ: ATNX) investors with significant losses to submit your losses now. Class Period: Aug. 7, 2019 \u2013 Feb. 26, 2021 Lead Plaintiff Deadline: May 3, 2021 Visit: www.hbsslaw.com\/investor-fraud\/ATNX Contact An Attorney Now: ATNX@hbsslaw.com \u00a0 844-916-0895 Athenex, Inc. (NASDAQ: ATNX) Securities Class Action: The Complaint alleges that throughout the Class Period, Defendants made false statements and omissions about its flagship drug candidate, an oral paclitaxel and encequidar for the treatment of metastatic breast cancer. Specifically, Defendants misrepresented and concealed that: (i) the data included in the Oral Paclitaxel plus Encequidar New Drug Application presented a safety risk to patients; (ii) there was uncertainty over the results of the … Continue reading \"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-05T17:38:30+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys","datePublished":"2021-04-05T17:38:30+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/"},"wordCount":495,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/","name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=","datePublished":"2021-04-05T17:38:30+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMTI1MSM0MTA1MTUyIzIwMTg1MzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/hagens-berman-national-trial-attorneys-alerts-athenex-atnx-investors-of-securities-fraud-lawsuit-and-application-deadline-encourages-investors-with-losses-to-contact-their-attorneys\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Athenex (ATNX) Investors of Securities Fraud Lawsuit and Application Deadline, Encourages Investors with Losses to Contact Their Attorneys"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470996"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}